The facility is acquired for a total consideration of USD 7.7 million, it added. As part of the acquisition, the existing workforce of the facility will transition into Biocon Generics Inc. The facility has the potential for capacity expansion of up to 2 billion tablets/capsules per year., The facility is acquired for a total consideration of USD 7.7 million, it added. As part of the acquisition, the existing workforce of the facility will transition into Biocon Generics Inc. The facility has the potential for capacity expansion of up to 2 billion tablets/capsules per year., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way